BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 20813341)

  • 21. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
    J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.
    He J; Farias S; Martinez O; Reed B; Mungas D; Decarli C
    Arch Neurol; 2009 Nov; 66(11):1393-9. PubMed ID: 19901172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
    Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study.
    Camarda C; Torelli P; Pipia C; Sottile G; Cilluffo G; Camarda R
    Curr Alzheimer Res; 2020; 17(8):766-780. PubMed ID: 33167837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.
    Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L;
    J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
    Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
    Wang J; Wang M; Ren S; Huang L; He K; Li J; Hua F; Guan Y; Guo Q; Huang Q; Xie F
    J Alzheimers Dis; 2023; 94(2):763-775. PubMed ID: 37334590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease.
    Brown PJ; Devanand DP; Liu X; Caccappolo E;
    Arch Gen Psychiatry; 2011 Jun; 68(6):617-26. PubMed ID: 21646578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
    J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review.
    Miao Y; Cui L; Li J; Chen Y; Xie X; Guo Q
    J Alzheimers Dis; 2022; 89(4):1131-1142. PubMed ID: 35988223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
    Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The
    Saeed U; Desmarais P; Masellis M
    Expert Rev Neurother; 2021 Aug; 21(8):851-870. PubMed ID: 34311631
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of APOE in mild cognitive impairment.
    Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC
    Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between the APOEɛ2/ɛ4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Alzheimers Dis; 2021; 81(3):943-948. PubMed ID: 33935088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.